Lifecare ASA: Mandatory notification of trade

The Company has been informed that Teigland Eiendom AS, a company closely associated with Trine Teigland, board member and primary insider of Lifecare ASA, has exercised 3,072,447 warrants in Warrants Series 1 for the subscription of 3,072,447 new shares in the Company at a price of NOK 0.3342 per share.

The Company has also been informed that Teigland Eiendom AS has sold 3,000,000 shares at a price of NOK 0.4824 per share.

Following this transaction, Teigland Eiendom AS holds 9,682,136 shares, no warrants in Warrant Series 1 and 7,860,000 warrants in Warrant Series 2 in the Company.

About us Lifecare ASA is a medical sensor company developing technology for sensing and monitoring of various body analytes. Lifecare's focus is to bring the next generation of Continuous Glucose Monitoring systems to market. Lifecare enables osmotic pressure as sensing principle. Lifecare's sensor technology is suitable for identifying and monitoring the occurrence of a wide range of analytes and molecules in the human body and in pets.

Contacts For further information, please contact:

Joacim Holter, CEO, joacim.holter@lifecare.no, +47 40 05 90 40

Renete Kaarvik, CFO, renete.kaarvik@lifecare.no, +47 94 83 82 42

This information has been submitted pursuant to the Securities Trading Act § 5-12 and MAR. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-03-13 16:49 CET.